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Abstract
Background: Recent studies in murine mammary tissue have identified functionally distinct cell populations that
may be isolated by surface phenotype or lineage tracing. Previous groups have shown that CD24medCD49fhigh cells
enriched for long-lived mammary epithelial cells can be serially transplanted.
Methods: Flow cytometry-based enrichment of distinct phenotypic populations was assessed for their gene expression
profiles and functional proliferative attributes in vitro and in vivo.
Results: Here, we show Thy-1 is differentially expressed in the CD24medCD49fhigh population, which allowed us to discern
two functionally different populations. The Thy-1+CD24medCD49fhigh phenotype contained the majority of the serially
transplantable epithelial cells. The Thy-1−CD24medCD49fhigh phenotype contains a rare progenitor population that is able
to form primary mammary outgrowths with significantly decreased serial in vivo transplantation potential.
Conclusions: Therefore, Thy-1 expression in the immature cell compartment is a useful tool to study the
functional heterogeneity that drives mammary gland development and has implications for disease etiology.
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Background
Mammary development is a highly ordered process that is
regulated by spatiotemporal cues and directed by local and
systemic signals [1]. Seminal studies in murine mammary
cell biology revealed that the CD24medCD49fhighCD29high
cell surface phenotype enriches for mammary repopulating
units (MRUs) that have the greatest in vivo proliferative
capacity, as measured by serial in vivo transplantation and
differentiation into specialized cell types [2, 3]. However,
the functional heterogeneity of phenotypically enriched
pooled-cell populations complicates descriptions of such
populations [4]. Therefore, there remains a need for better
phenotypic markers to prospectively enrich for different
functional cell populations that can be used to characterize
these populations transcriptionally or precisely mark cer-
tain populations using lineage-tracing strategies. Thy-1, or
CD90, is a GPI-anchored cell surface protein that was ori-
ginally described as a mouse brain and thymus marker.
Subsequent studies have shown that the Thy-1 antigen is
expressed on many cell types, including hematopoietic stem
cells (partially reviewed in [5, 6]). Thy-1 is expressed by
basal cells in normal human mammary epithelium [7],
where stem cells are thought to reside. Using the
Thy-1+CD24+ phenotype, our group prospectively enriched
for tumorigenic cells from a subset of MMTV-Wnt1 mur-
ine mammary tumors that share properties with normal
murine MRUs (mammary repopulating units, also known
as stem cells) [8, 9]. Therefore, we sought to improve upon
the current murine MRU cell surface phenotype by func-
tionally assessing the prospective enrichment of serially
transplantable mammary cells using Thy-1 expression. Our
data revealed that Thy-1 expression on immature cells en-
riches for serially transplantable MRUs. Interestingly, the
immature cells that lack Thy-1 expression enriched for a
previously unknown rare population, which we term
short-term mammary repopulating units (ST-MRUs), with
limited serial proliferative potential in vivo.
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Methods
Mouse strains
C57BL/6 and FVB mice were purchased from The Jackson
Laboratory, Bar Harbor, ME, USA. pCx-GFP founder mice
were kindly provided by Dr. Irving Weissman. All animals
were maintained at the Stanford Animal Facility in ac-
cordance with the guidelines of both Institutional Animal
Care Use Committees.
Mammary gland dissociation and FACS
Six- to 10-week-old mice were euthanized and all fat pads
surgically resected. Tissue was digested in Media 199 +
10 mM HEPES + PSA or L-15 for 2 h, and single-cell sus-
pension was obtained as described previously [2] and then
processed as described by the manufacturer’s instructions
for Epicult (Stemcell Technologies, Vancouver, BC,
Canada). For all experiments, cells were > 99% viable as
assessed by Trypan Blue dye exclusion. Cells were then
resuspended at a concentration of 1 × 107 per ml and sub-
jected to staining for flow cytometry. The antibodies
CD24-PE, Thy-1.1-APC, Thy-1.1-PE-CY7, Thy-1.2-APC,
and Thy-1.2-PE-CY7 were obtained from eBioscience
(San Diego, CA, USA), CD45-BIO, Ter119-BIO,
CD31-BIO, and CD140α-BIO were obtained from BD
Pharmingen (San Jose, CA, USA), and Streptavidin-Pacific
Blue was obtained from Invitrogen (Carlsbad, CA, USA).
FACS for all experiments was performed on BD FACSAria
II equipped with a UV laser. All gating to distinguish posi-
tive and negative expression was based upon IgG-isotype
color-specific control staining.
In vitro colony-forming assay
Ultra-low attachment 96-well plates (BD, Franklin Lakes,
NJ, USA) were prepared with a feeder layer of irradiated
L1-WNT3a mixed with 60 μl of growth factor-reduced
Matrigel (BD) per well. Sorted cells were then plated
into liquid media as previously described [10, 11] 10%
FBS, 250 ng/ml Rspo I (R&D Systems, Minneapolis,
MN, USA) and 2.5% growth factor-reduced Matrigel
were added as supplements. 5 ng/ml purified mouse
TGFβ1 ligand (R&D Systems) was added to wells as
indicated. Colonies were counted after 7 days in culture
in a 5% CO2 incubator.
In vivo transplants
Sorted cell populations were collected in HBSS + 2%
HICS and resuspended at the correct concentration
before being injected into the cleared fat pads of 21–
28-day-old recipient C57Bl/6 mice as previously de-
scribed [2]. For all injections of 600 cells and below, cell
counts were verified using either a nuclear staining
count (1% Trypan Blue/0.1% Triton-X 100 in PBS) or
GFP+ cell count. Cells were injected in either 10 or 5 ul
volumes of PBS using a 25 ul Hamilton syringe. All
transplants were allowed to grow for at least 5 weeks,
but not more than 10 weeks before analysis. In the case
of secondary and tertiary transplants, whole glands were
dissected under fluorescence to obtain 1–2 mm pieces
of tissue that contained GFP+ ductal structures that were
transplanted into recipient mice.
Whole mount and immunocytochemistry
Whole mounts stained with carmine alum were proc-
essed according to a standard protocol [12]. For
immunocytochemistry, mammary glands were fixed in
formalin and embedded in paraffin. Three-micrometer
sections were dewaxed, hydrated and microwaved for
20 min in Tris-EDTA (0.01 M; pH 9) for antigen re-
trieval. Tissue sections were incubated overnight at 4 °C
with primary antibodies in TBS + 1% BSA. Antibodies
were CK6 (Covance, Princeton, NJ, USA), CK5 (Covance),
Troma-I (DSHB, Iowa City, IA, USA) and Troma-III
(DSHB). Sections were then incubated with anti-rat–Alexa
A488 antibody and anti-rabbit–A594 antibody (both from
Invitrogen) for 30 min at room temperature. Secondary
antibodies were applied at 1:200 dilution. Samples were
stained with DAPI and mounted in ProLong before pic-
tures were taken. All images were produced with a Leica
(Wetzlar, Germany) microscope and Image Pro Software
(Media Cybernetics, Rockville MD, USA).
RNA isolation and RT-PCR
Sorted cell populations were collected in staining media
directly and then centrifuged at 5000 rpm for 5 min at 4
°C. Supernatant was then carefully removed from the
cell pellet, which was immediately frozen in liquid N2
and stored at −80 °C until RNA extraction. RNA was
extracted from frozen cell pellets by the Trizol method
or MirVana kit (Life Technologies, Carlsbad, CA, USA).
For RT-PCR, RNA was then converted to cDNA using the
Superscript III Reverse Transcriptase system (Invitrogen).
qPCR was then performed on fresh cDNA with 2 × SYBR
Green Master Mix (Applied Biosystems, Foster City, CA,
USA) according to the manufacturer’s instructions with
primers to amplify specific genes (available upon request).
Microarrays and expression analysis
RNA was then processed for microarray hybridization
by the Stanford Protein and Nucleic Acids core facility.
RNA was applied to Affymetrix (Santa Clara, CA, USA)
GeneChip Mouse Genome 430 2.0 oligonucleotide
arrays. The resulting CEL images were then processed
using the TIGR TM4 [13, 14] suite of bioinformatic soft-
ware. Arrays were pre-processed by MIDAS using robust
multichip average (RMA) normalization across all sam-
ples. Using Cluster 3.0 [15], probes that expressed less
than 6.229 (in Log2 space) in any two of the arrays and
whose value was not at least fourfold different in any
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two arrays were excluded from the analyses. Probes in-
tensities were then mean centered across all arrays as a
set. Using MeV (TIGR), Rank products algorithm was
then used to compare different populations using
two-class unpaired comparisons with a critical p value of
0.01 for differentially expressed probes. Heatmaps are
scaled from −3.0 (low) to 3.0 (high) in Log2 space.
Microarray data may be found at GenBank under acces-
sion GSE89720.
Results
Thy-1 enriches for a molecularly distinct subset of
CD24medCD49fhigh cells
Previous studies have shown CD49f and CD24 are cell sur-
face markers that are able to distinguish self-renewing
MRUs (CD24medCD49fhigh) from basal myoepithelial cells
(CD24lowCD49fmed), CD24highCD49fmed colony-forming
cells, and CD24medCD49f−/low luminal cells [2, 3]. We found
that Thy-1 was expressed on ~30% of luminal cell popula-
tions and ~50% of CD24medCD49fhigh and myoepithelial
cells (Fig. 1a, b, c, d). We also found that Thy-1 was
expressed by CD24med/highCD133+Sca-1+ hormone-sensing
luminal progenitor cells [16] as well as CD61+ luminal pro-
genitor cells [17] (Additional file 1: Figure S1A). Real-time
PCR confirmed the basal or luminal identity of sorted popu-
lations based on the expression of Smaα and Krt14 (basal
marker) and Krt18 and Krt19 (luminal marker) genes,
respectively (Fig. 1e and f). To test if our enrichment proce-
dures dramatically altered the physiology of the sorted popula-
tions, we exposed sorted populations to TGFβ1, a well-studied
ligand that is associated with epithelial-to-mesenchymal transi-
tion [18]. Sorted populations that expressed basal or luminal
gene markers shared similar responses to TGFβ1 exposure
(Additional file 1: Figure S1B). Therefore, the sorting paradigm
and related procedures effectively enriched for physiologically
distinct phenotypic populations.
Numerous studies have linked the transcriptional ex-
pression of key genes to the function of cells enriched
for by cell surface demarcation or lineage-tracing strat-
egies [16, 19]. For example, Tbx3 is a gene that regulates
the development of mammary hormone-sensing cells
[20]. Interestingly, we found that all populations except
for the Thy-1 expressing CD24medCD49fhigh cells also
expressed Tbx3 (Fig. 1g). This population also had a low
transcriptional level of Cdkn1a (Fig. 1h), whose expres-
sion is associated with halted cell cycle progression,
comparable to luminal CD24highCD49fmed cells that have
been previously characterized to be highly proliferative.
Furthermore, single-cell RNA-Seq data from the Marioni
and Khaled laboratories showed that Thy-1 is most
highly expressed in cells that are enriched for Procr, a
Wnt target gene that has been linked to multipotent
mammary stem cells [21] (Fig. 1i). Taken together, these
results suggested that Thy-1 does indeed segregate a
functionally distinct subpopulation of CD24medCD49fhigh
cells.
To further investigate the transcriptional differences
that define each population, we performed gene expres-
sion microarrays on sorted cell populations. We found
that Thy-1+CD24medCD49fhigh, Thy-1−CD24medCD49fhigh,
and CD24lowCD49fmed cells had unique global gene
expression profiles in both C57BL6 and FVB mice (Fig. 2a,
b, Additional file 2: Figure S2A and B). There were both
strain-specific and distinct genes expressed by sorted
populations (Additional file 3). Notably, the Thy-
1+CD24medCD49fhigh cells expressed the highest level of
genes that have previously been linked to mammary
gland stem cells such as Rarres2 and Aldh1a1 [22, 23]
(Fig. 2a). The enriched expression of Rarres1 and
Aldh1a1 in both mouse strains’ microarray data in the
Thy-1+CD24medCD49fhigh cells was confirmed by real-time
PCR and in Procr-enriched cells by single-cell RNA-seq
from the Marioni and Khaled laboratories [24] (Additional
file 1: Figure S1C, D, E, F). The Thy-1+CD24medCD49fhigh
population was also enriched for the expression of Procr
by real-time PCR (Additional file 1: Figure S1E), with the
Procr-enriched population expressing high levels of both
Procr and Thy-1 by single-cell RNA-seq (Fig. 1i and
Additional file 1: Figure S1H). We also observed that
CD24highCD49fmed luminal cells expressed genes that dis-
tinguished this population from CD24medCD49f−/low lu-
minal cells in both the C57BL6 and FVB mouse strains
(data not shown, Additional file 2: Figure S2C and Add-
itional file 3). In the BL6 strain, the CD24medCD49f−/low
population was enriched for the expression of Elf5, a tran-
scription factor that suppresses mammary stem cell activity
[25] (Additional file 3).
Thy-1 enriches for an extensively proliferating subset of
CD24medCD49fhigh cells
Murine mammary stroma depleted of endogenous epi-
thelium provides an excellent in vivo model system to
assess the repopulating potential and frequency of im-
planted cell populations. We leveraged this system and
transplanted sorted cell populations from pCx-GFP trans-
genic mouse cells that ubiquitously express GFP to distin-
guish donor outgrowths from any residual endogenous
epithelium. We found that 100 Thy-1+CD24medCD49fhigh
and 100 Thy-1−CD24medCD49fhigh cells were able to pro-
duce GFP+ ductal outgrowths that looked morphologically
similar to those produced by 100 bulk mammary epithelial
cells (MECs) (Fig. 3a). However, neither luminal
CD24highCD49fmed progenitor cells, CD24medCD49f−/low
luminal cells, nor CD49fmedCD24low differentiated myoe-
pithelial cells were able to produce extensive outgrowths
up to 10,000 cells transplanted (Fig. 3a and data not
shown). Limiting dilution transplantation studies revealed
that the frequency of engrafting cells in the total
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CD24medCD49fhigh population was 1 in 254 cells, consistent
with previous reports (Fig. 3b, c, Additional file 4: Figure
S3A). Strikingly, we observed that the majority of the
outgrowth-forming ability was confined to CD24medCD49f-
high cells that also expressed Thy-1 (Fig. 3b, c, Additional
file 4: Figure S3A). Single-cell transplantation revealed that
one in eight cells from the Thy-1+CD24medCD49fhigh popu-
lation were able to produce clonal outgrowths (Fig. 3d).
Previous reports using limiting dilution transplantation
studies revealed that the MRU frequency within the
CD24medCD49fhigh phenotype might be influenced by
the strain of mice employed [2, 3]. Therefore, we per-
formed another set of limiting dilution transplantation
experiments in wild-type (WT) FVB mice (Additional
file 4: Figure S3B). Again, we found that CD24medCD49f-
high cells that also expressed Thy-1 contained most of
the outgrowth-forming cells (Additional file 4: Figure
S3C). In FVB mice, the Thy-1−CD24medCD49fhigh cells
gave rise to smaller ductal outgrowths that were largely
devoid of side branching structures (Additional file 4:
a b
c
e f
g h i
d
Fig. 1 Thy-1 is differentially expressed in murine mammary epithelium. Freshly dissociated mammary epithelium analyzed for the expression of
CD24 and CD49f. Thy-1 expression in (a) CD24highCD49fmed MaCFC luminal progenitor (b) CD24medCD49f−/low luminal (c) CD24medCD49fhigh and
(d) CD24lowCD49fmed myoepithelial cells. e Real-time PCR of sorted populations for basal marker genes’ expression. N = 3, ± STD. f Real-time PCR
of sorted populations for luminal marker genes’ expression. N = 3, ± STD. g Real-time PCR of sorted populations for Tbx3 expression. N = 3, ± STD.
**p < 0.01, *p < 0.05 for an unpaired two-tailed t test. h Real-time PCR of sorted populations for Cdkn1a (p21) expression. N = 3, ± STD. *p < 0.05
for an unpaired two-tailed t test. i Thy-1 expression in mouse mammary epithelial from single-cell RNA-seq data using the web tool
(http://marionilab.cruk.cam.ac.uk/mammaryGland/) from Bach et al. [24]. C15 cells are annotated as Procr-enriched cells
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Figure S3D). The frequency of outgrowth-forming cells
in the Thy-1+CD24medCD49fhigh population was 1 in 156
cells in FVB mice, similar to the frequency in C57BL6
mice (Additional file 4: Figure S3E).
Thy-1+CD24medCD49fhigh enriches for transplanted
outgrowths with serial transplantation potential
MRUs are defined as cells that have both the ability to
self-renew and to differentiate into mature luminal and
basal cells that give rise to functional milk-secreting
epithelium. The presence of MRUs can be detected by
serially passaging transplanted cells or tissue fragments
in vivo since only cells with extensive proliferative
capacity will be able to continually produce outgrowths
[3, 26]. Our initial transplantation data showed that the
Thy-1+CD24medCD49fhigh phenotype contained most of
the outgrowth-forming cells. We serially transplanted
2 mm3 fragments of GFP+ donor epithelium from the ini-
tial primary outgrowths that were produced by C57BL6
Thy-1+CD24medCD49fhigh, or Thy-1−CD24medCD49fhigh
GFP+ cells and found these outgrowths grew secondary
GFP+ structures (Fig. 4a). A total of 23 out of 33
Thy-1+CD24medCD49fhigh primary GFP+ epithelial frag-
ments engrafted upon secondary transplantation, giving
an engraftment efficiency of about 67% (Additional file 5:
Figure S4A). We found that Thy-1+CD24medCD49fhigh
cells were able to give rise to secondary ductal outgrowths
that resembled the outgrowths formed from bulk MECs
and the phenotypic CD24, CD49f and Thy-1 diversity of
WT glands (Figs. 1 and 4c). Thy-1+CD24medCD49fhigh pri-
mary outgrowths were also able to give rise to tertiary out-
growths similar to bulk MECs (Additional file 5: Figure
S4B). Strikingly, we found that only 11% of the GFP+ frag-
ments produced by Thy-1−CD24medCD49fhigh trans-
planted cells were able to form secondary outgrowths
(Additional file 5: Figure S4A). In addition, the secondary
outgrowths were much smaller than those produced by
initially engrafted GFP+ Thy-1+CD24medCD49fhi cells
(Fig. 4a). Unlike the Thy-1+CD24medCD49fhigh epithe-
lium that produced tertiary outgrowths like bulk MECs,
the few GFP+ secondary outgrowths formed by the ini-
tially engrafted GFP+Thy-1−CD24medCD49fhi cells were
unable to re-engraft a third time (Fig. 4a). These data
demonstrated that Thy-1+CD24medCD49fhigh phenotype
enriched for MRUs and that the Thy-1−CD24medCD49fhi
phenotype cells were enriched for basal short-term MRUs
(ST-MRUs) with less proliferative capacity.
Functionally competent mammary epithelium will be
able to give rise to alveolar milk-secreting cells upon
pregnancy. We took mice that were engrafted with sec-
ondary GFP+ outgrowths produced by bulk MECs and
Thy-1+CD24medCD49fhigh cells at 10 weeks posttrans-
plantation and mated them to determine the
milk-producing capability outgrowths. Hematoxylin and
eosin staining showed extensive expansion of the ductal
epithelium (Additional file 5: Figure S4C). Cytokeratin
staining showed CK14, CK8, CK19, and CK6 localization
was indistinguishable between WT (non-transplanted),
primary, and secondary GFP+ transplanted epithelium
Fig. 2 Microarray analysis of sorted mammary populations from
virgin C57BL6 mice. Thy + MRU represents Thy-1+CD24medCD49fhigh,
Thy-MRU represents Thy-1−CD24medCD49fhigh, and MYO represents
CD24lowCD49fmed. a Differentially expressed probes comparing
Thy-1+CD24medCD49fhigh to both Thy-1−CD24medCD49fhigh and
CD24lowCD49fmed basal populations. b Differentially expressed
probes comparing Thy-1−CD24medCD49fhigh to both Thy-
1+CD24medCD49fhigh and CD24lowCD49fmed basal populations
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produced by Thy-1+CD24medCD49fhigh cells (Additional
file 5: Figure S4C). In addition, Thy-1+CD24medCD49fhigh
secondary outgrowths underwent pregnancy morphogen-
esis in a similar fashion to WT epithelium as evaluated by
cytokeratin expression, with visual confirmation of milk
inside of the lumen of ducts in hematoxylin and eosin
staining (Fig. 4c).
Discussion
Prospective isolation studies have shown that mammary
tissue contains a distinct cell population of MRUs that is
enriched for the ability to establish a functionally com-
petent mammary gland in serial transplantation assays
[2, 3]. We found that the Thy-1+CD24medCD49fhigh
phenotype enriches for mammary cells with the highest
proliferative capacity as measured by this assay. Surpris-
ingly, we found single-cell transplantation revealed a highly
enriched MRU frequency in the Thy-1+CD24medCD49fhigh
cells compared to pooled-cell transplants, which may be due
to multiple progenitor cells competing for sparse niche com-
ponents. We also noted that the Thy-1+CD24medCD49fhigh
cells expressed genes associated with these cells with extensive
proliferation capacity [22]. Since the Thy-1−CD24medCD49fhigh
population contains cells with diminished capacity to serially
form extensive ductal outgrowths in vivo, these cells may be
comparable to multipotent progenitor cells in the
hematopoietic system, which also have a lesser proliferative
capacity compared to stem cells. To our knowledge, this is the
first report of the existence of a mammary epithelial cell popu-
lation with short-term MRU capacity. In addition to MRUs,
unipotent progenitor cells have been identified and bipotent
progenitor cells that lack in vivo transplantation capacity have
been previously described [2, 27].
We found that the ortholog of TBX3, a gene mutated in
ulnar mammary syndrome (UMS), was expressed in all
populations except for Thy-1+CD24medCD49fhigh. Recent
studies have shown that Tbx3 is required for the mam-
mary development and generation of hormone-sensing
cells in murine mammary epithelium [28, 29]. Our data
suggests that the UMS breast phenotype may be a defect
of aberrant specification of cells with the capacity to
undergo terminal differentiation. Recent studies have also
demonstrated that Elf5 expression is necessary for the dif-
ferentiation of luminal progenitor cells [25]. Our data
showing that the CD24medCD49f−/low compartment
expresses Elf5 suggests that this compartment participates
in a feedback pathway that instructs mammary epithelial
cells to proliferate and differentiate.
Conclusions
Taken together, our data shows that the inclusion of
Thy-1 expression to the growing list of phenotypic
markers will allow further dissection of the mammary
cellular hierarchy and allow for more accurate interpret-
ation of pooled or single-cell analyses.
a b
c
d
Fig. 3 Thy-1+CD24medCD49fhigh is enriched for ductal outgrowth-forming MRUs. a Representative images of primary transplanted ductal epithelium
produced by 100 transplanted cells of the indicated GFP+ sorted population. Scale bars show 500 μm. b Summary of limiting dilution transplantation
series. c Estimated frequency of ductal outgrowth-forming cells in the indicated transplanted population. d Representative image and frequency of
ductal outgrowths from single-cell transplants of GFP+Thy-1+CD24medCD49fhigh. Scale bar shows 500 μm
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Additional files
Additional file 1: Figure S1. Phenotypic and physiological analysis of
sorted populations. (A) Flow cytometric analysis on luminal cells for Thy-
1, CD133, Sca-1, and CD61 expression. (B) Exposure of cultured FACS-
enriched mammary populations to TGFB1 ligand. The indicated sorted
mammary populations were cultured in three-dimensional self-renewing
conditions with and without the addition of 5 ng/ml human TGFB1 ligand.
N = 3, ± STD. (C) Real-time PCR of sorted populations for Procr expression.
N = 3, ± STD. *-p < 0.05 for an unpaired two-tailed t test. (D) Procr expression
in mouse mammary epithelial from single-cell RNA-seq data using the web
tool (http://marionilab.cruk.cam.ac.uk/mammaryGland/) from Bach et al. [24].
C15 cells are annotated as Procr-enriched cells. (E) Real-time PCR of sorted
populations for Rarres2 expression. N = 3, ± STD. *p < 0.05 for an unpaired
two-tailed t test. (F) Rarres2 expression in mouse mammary epithelial from
single-cell RNA-seq data using the web tool (http://marionilab.cruk.cam.a-
c.uk/mammaryGland/) from Bach et al. [24]. C15 cells are annotated as
Procr-enriched cells. (G) Real-time PCR of sorted populations for Aldh1a1
expression. N = 3, ± STD. *p < 0.05 for an unpaired two-tailed t test. (H)
Aldh1a1 expression in mouse mammary epithelial from single-cell RNA-seq
data using the web tool (http://marionilab.cruk.cam.ac.uk/mammaryGland/)
from Bach et al. [24]. C15 cells are annotated as Procr-enriched cells.
(PDF 293 kb)
Additional file 2: Figure S2. Microarray analysis of phenotypically
enriched populations isolated from virgin FVB female mice. (A) Differentially
expressed probes comparing Thy-1+CD24medCD49fhigh to both Thy-
1−CD24medCD49fhigh and CD24lowCD49fmed basal populations. (B) Differen-
tially expressed probes comparing Thy-1−CD24medCD49fhigh to both Thy-
1+CD24medCD49fhigh and CD24lowCD49fmed basal populations. (C) Differen-
tially expressed probes comparing CD24highCD49fmed to CD24medCD49f−/low
luminal cells. (PDF 186 kb)
Additional file 3: Strain and sorted population-specific and overlapping
gene sets. Using the microarray data from C57BL6 and FVB mouse strains,
each population’s significantly enriched genes’ expression was compared
to determine the overlapping genes as well as the strain-specific genes.
File contains tabular sheets of data that correspond to Thy-1+CD24medCD49f-
high, Thy-1−CD24medCD49fhigh, CD24lowCD49fmed, CD24highCD49fmed,
and CD24medCD49f−/low populations. (XLSX 65 kb)
Additional file 4: Figure S3. Limiting dilution transplantation series in
C57BL/6 and FVB mice. (A) Numbers of cells engrafted and ductal outgrowth
data from limiting dilution transplantation series in C57BL6 mice from the
indicated sorted populations. (B) Numbers of cells engrafted and ductal
outgrowth data from limiting dilution transplantation series in FVB mice from
the indicated sorted populations. (C) Summary of limiting dilution
transplantation series from FVB mice. (D) Representative images of
FVB-derived ductal outgrowths from the indicated populations. (E)
Estimated frequency of ductal outgrowth forming cells in the indicated
transplanted population from FVB mice. (PDF 487 kb)
Additional file 5: Figure S4. Thy-1+CD24medCD49fhigh MRUs produce
functional mammary epithelium. (A) Secondary transplant data from the
indicated originally transplanted sorted population. (B) Tertiary transplant
data from the indicated originally transplanted sorted population. (C)
Hematoxylin and eosin and immunofluorescence staining of the indicated
cytokeratin proteins in wild-type (WT) and serially transplanted Thy-
1+CD24medCD49fhigh epithelium. “Preg” denotes recipient mice that
hosted donor ductal outgrowths that were mated and tissue analyzed at
11 days into pregnancy. (PDF 1889 kb)
Abbreviations
MEC: Mammary epithelial cell; MRU: Mammary repopulating unit; ST-
MRU: Short-term mammary repopulating unit; UMS: Ulnar mammary
syndrome; WT: Wild-type
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